We are live on
!
Find out more
Q
QVR Portfolio holdings
AUM
$2.49B
1-Year Est. Return
48.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.73%
1 Year Est. Return
+48.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$423M
AUM Growth
-$1.11B
(-72%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-271.38%
Top 10 Holdings %
Top 10 Hldgs %
99.94%
Holding
312
New
1
Increased
–
Reduced
13
Closed
298
Top Buys
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$106M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$6.63M |
| 2 |
Apple
AAPL
|
+$3.25M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.54M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$2.41M |
Sector Composition
| 1 | Healthcare | 0.09% |
| 2 | Financials | 0.06% |
| 3 | Technology | 0.04% |
| 4 | Energy | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$82.2B
| $222M | 52.54% |
1,000,000
-1,114,400
| -53% | -$252M |
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $110M | 25.98% |
+231,591
| New | +$106M |
|
3
PUT
Invesco QQQ Trust
QQQ
$466B
| $87.5M | 20.67% |
220,000
-449,000
| -67% | -$173M |
|
4
PUT
Bank of America
BAC
$430B
| $1.5M | 0.36% |
33,800
-109,700
| -76% | -$5M |
|
5
PUT
Accenture
ACN
$87.9B
| $663K | 0.16% |
1,600
-6,600
| -80% | -$2.41M |
|
6
Gilead Sciences
GILD
$167B
| $229K | 0.05% |
3,157
-286
| -8% | -$19.7K |
|
7
PUT
Pfizer
PFE
$143B
| $212K | 0.05% |
3,600
-73,300
| -95% | -$3.63M |
|
|
8
Berkshire Hathaway Class B
BRK.B
$1.06T
| $208K | 0.05% |
696
-8,430
| -92% | -$2.41M |
|
9
PUT
Blackrock
BLK
$166B
| $183K | 0.04% |
200
-1,500
| -88% | -$1.37M |
|
|
10
Accenture
ACN
$87.9B
| $170K | 0.04% |
410
-947
| -70% | -$345K |
|
|
11
Pfizer
PFE
$143B
| $158K | 0.04% |
2,671
-4,974
| -65% | -$246K |
|
|
12
Blackrock
BLK
$166B
| $35K | 0.01% |
38
-155
| -80% | -$141K |
|
|
13
CALL
Pfizer
PFE
$143B
| $35K | 0.01% |
600
-73,500
| -99% | -$3.64M |
|
|
14
CALL
Gilead Sciences
GILD
$167B
| $7K | ﹤0.01% |
100
-20,500
| -100% | -$1.41M |
|
|
15
CALL
Apple
AAPL
$4.9T
| – | – |
-180,000
| Closed | -$25.5M |
|
|
16
Apple
AAPL
$4.9T
| – | – |
-22,977
| Closed | -$3.25M |
|
|
17
PUT
Apple
AAPL
$4.9T
| – | – |
-235,800
| Closed | -$33.4M |
|
18
CALL
AbbVie
ABBV
$450B
| – | – |
-16,900
| Closed | -$1.82M |
|
|
19
AbbVie
ABBV
$450B
| – | – |
-3,599
| Closed | -$388K |
|
|
20
PUT
AbbVie
ABBV
$450B
| – | – |
-36,200
| Closed | -$3.9M |
|
21
CALL
Abbott
ABT
$175B
| – | – |
-21,800
| Closed | -$2.58M |
|
|
22
Abbott
ABT
$175B
| – | – |
-6,859
| Closed | -$810K |
|
|
23
PUT
Abbott
ABT
$175B
| – | – |
-32,500
| Closed | -$3.84M |
|
|
24
CALL
Accenture
ACN
$87.9B
| – | – |
-7,000
| Closed | -$2.24M |
|
25
CALL
Adobe
ADBE
$94.3B
| – | – |
-5,100
| Closed | -$2.94M |
|
Similar funds
SIM
FFA
BL
SG
JC
TW
SCM
PAI
QVR's Q4 2021 Portfolio in Review
As of Q4 2021, QVR held 312 positions worth $423M, down 72% from $1.53B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
QVR withdrew a net $1.15B in Q4 2021, closing 298 positions and reducing 13 holdings. Its most notable exit was Microsoft, an estimated $6.63M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0.09% of assets, down from 0.4% a quarter earlier, followed by Financials and Technology.
Against the trend, QVR opened a new position in State Street SPDR S&P 500 ETF Trust worth $110M.
- QVR's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 231,591 shares worth $110M.
- QVR's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $2.41M.
- QVR fully exited Microsoft in Q4 2021, selling an estimated $6.63M.
- QVR's ten largest holdings make up 100% of its $423M portfolio in Q4 2021.
- QVR opened 1 new position and closed 298 in Q4 2021.
- QVR's portfolio value fell 72% quarter-over-quarter to $423M.
Based on QVR's 13F filing for Q4 2021, filed 31 Jan 2022.